trial · primary record
Metformin
Type 1 Diabetes Mellitus
| Phase | Phase 3 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | Not stated |
| Primary completion | 2024-12-31 |
| Primary endpoint | Change in GLP-1 (glucagon like peptide) and GIP (gastric inhibitory peptide) postprandial secretion |
| Registry ID | NCT04177303 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:42.757Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04177303
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Metformin · compound